🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to evaluate the safety and efficacy of Xyrem...
Status
Completed
Location
East Alabama Arthritis Center
Start Date
2006-12
Trial ID
NCT00423813
The study aims at deepen the proof level of sodium oxybate use for comfort ...
Status
Completed
Location
Centre Hospitalier Princesse Grace
Start Date
2021-10-14
Trial ID
NCT05085873
Treatments Being Tested
To monitor for endocrine changes in response to treatment of cataplexy with...
Status
Completed
Location
Multiple Locations
Start Date
2006-04-10
Trial ID
NCT00345800
Treatments Being Tested
Sleep wake disturbance is a common problem in Parkinson's disease patients ...
Status
Completed
Location
Department of Neurology
Start Date
2014-04
Trial ID
NCT02111122
Treatments Being Tested
The purpose of this trial is to assess the efficacy and safety of Xyrem in ...
Status
Completed
Location
Miller Children's Hospital - Long Beach
Start Date
2014-10-01
Trial ID
NCT02221869
Treatments Being Tested
This clinical trial is designed to evaluate the safety and potential effica...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00641186
Treatments Being Tested
Chronic fatigue syndrome is a disabling illness for which there is no speci...
Status
Terminated
Location
UMDNJ - Pain & Fatigue Study Center, ADMC 1618
Start Date
2007-05
Trial ID
NCT00498485
Treatments Being Tested
Xyrem (sodium oxybate) is an agent with the propensity to improve slow wave...
Status
Withdrawn
Location
SUNY Upstate Medical University
Start Date
2005-08
Trial ID
NCT00330291
Treatments Being Tested
A pre-post study will be conducted to assess whether treatment with LXB, nV...
Status
Enrolling By Invitation
Location
Leiden University Medical Center (LUMC)
Start Date
2025-03-27
Trial ID
NCT06421532
Treatments Being Tested
Patients will be followed up for max 18 months. Information on the Adverse ...
Status
Completed
Location
9
Start Date
2006-05
Trial ID
NCT00244465